| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 09/28/2005 | CN1673223A Dihydromyricitrin fatty ester preparing process |
| 09/28/2005 | CN1673222A Baicalin preparing process |
| 09/27/2005 | US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease |
| 09/27/2005 | US6949537 LY294002 and analogs thereof comprising a reversibly quaternized amine; use of the pro-compounds for treatment of a condition associated with PI-3 kinase activity, including inflammatory disease, age-related macular degeneration, hypertension |
| 09/27/2005 | US6949341 Diagnosing genetic disorders |
| 09/22/2005 | WO2005087758A1 Water-soluble bound matter of proanthocyanidin and composition containing the same |
| 09/22/2005 | WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 09/22/2005 | WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors |
| 09/22/2005 | WO2005054809A3 Irciniastatins a and b |
| 09/22/2005 | US20050209314 Novel benzopyran analogs and their use for the treatment of glaucoma |
| 09/22/2005 | US20050209313 Flavonoid concentrates |
| 09/22/2005 | US20050209283 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 09/22/2005 | US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction |
| 09/22/2005 | US20050209171 Treatment of periodontal disease |
| 09/22/2005 | US20050208001 rosacea, intrinsic or chronological aging, pigmentation, seborrhoeic function, barrier function, epidermal lipid secretion, wound healing, atrophies, ulcers, immune system, cardiovascular system disorders; 6-(5,6,7,8-tetrahydro-5,5,8,8-tetra-methylnaphthalene-2-carbonyl)naphthalene-2-carboxylic acid |
| 09/22/2005 | CA2558975A1 Water-soluble bound matter of proanthocyanidin and composition containing the same |
| 09/22/2005 | CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 09/21/2005 | EP1577315A1 Process for producing hop glume polyphenol |
| 09/21/2005 | EP1577308A2 Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors |
| 09/21/2005 | EP1577288A1 Selective estrogen receptor modulators |
| 09/21/2005 | EP1575575A2 Safe chemical uncouplers for the treatment of obesity |
| 09/21/2005 | CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same |
| 09/21/2005 | CN1671680A Compound for treatment of anxiety and methods of preparation and use thereof |
| 09/21/2005 | CN1671374A Color-stable, low impurity tocopherol compositions and processes for preparing the same |
| 09/21/2005 | CN1671373A Compounds useful for the inhibition of ALDH |
| 09/15/2005 | WO2005085811A1 Fluorescent probes |
| 09/15/2005 | WO2005085223A1 Composition for prevention and/or treatment of bone disease, functional food or health food containing the composition, and medicinal preparation containing the composition as active ingredient |
| 09/15/2005 | WO2005085188A2 Compounds and methods for anti-tumor therapy |
| 09/15/2005 | WO2005084689A1 Radix astragli extract and production method and use thereof |
| 09/15/2005 | US20050203173 PI-3 kinase inhibitor prodrugs |
| 09/15/2005 | US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
| 09/15/2005 | US20050203128 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide |
| 09/15/2005 | US20050203112 Bicyclic amides |
| 09/15/2005 | DE102004009096A1 Lederhilfsmittel Lederhilfsmittel |
| 09/14/2005 | EP1574507A2 Furo- and pyrano-naphthoquinones and their use in the treatment of cancer |
| 09/14/2005 | EP1574506A1 Remedies |
| 09/14/2005 | EP1572696A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
| 09/14/2005 | EP1572675A1 New alpha-glucosidase inhibitors and their synthesis from a natural source |
| 09/14/2005 | EP1572674A1 A process for the preparation of (-)-epicatechin from a new natural source namely dichrostachys cinerea |
| 09/14/2005 | EP1572673A1 Antioxidant from natural source |
| 09/14/2005 | EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 09/14/2005 | EP1572219A1 Efficient method for producing compositions enriched in total phenols |
| 09/14/2005 | EP1073418A4 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 09/14/2005 | CN1668608A Heterodiamondoids |
| 09/14/2005 | CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress |
| 09/14/2005 | CN1668574A Process for the preparation of phenylalanine enamide derivatives |
| 09/14/2005 | CN1668565A Substituted 1, 3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
| 09/14/2005 | CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 09/14/2005 | CN1666987A Process for synthesizing luteolin |
| 09/14/2005 | CN1218928C Method for preparing Duosairuilong compound and application thereof |
| 09/09/2005 | WO2005082880A1 DIBENZO CHROMENE DERIVATIVES AND THEIR USE AS ERβ SELECTIVE LIGANDS |
| 09/09/2005 | WO2005082879A1 Coumarin derivative and use thereof |
| 09/09/2005 | WO2005082841A1 Immunosuppressant compounds and compositions |
| 09/09/2005 | WO2005082352A1 Oxydecahydronaphthalene modulators of hm74 |
| 09/09/2005 | WO2005082351A1 Therapeutic agent for neurodegenerative disorder |
| 09/09/2005 | CA2557162A1 Coumarin derivative and use thereof |
| 09/09/2005 | CA2556889A1 Dibenzo chromene derivatives and their use as er.beta. selective ligands |
| 09/09/2005 | CA2553572A1 Immunosuppressant compounds and compositions |
| 09/08/2005 | US20050197362 Preventives/remedies for urinary disturbance |
| 09/07/2005 | EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 09/07/2005 | CN1663954A Process for preparing flavone in wampee |
| 09/07/2005 | CN1217936C Heterocyclic compounds having sulfonamide |
| 09/07/2005 | CN1217652C Cosmetic method of treating skin |
| 09/06/2005 | US6939977 For improved binding of CB1/CB2 receptors; side effects reduction |
| 09/06/2005 | US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine, |
| 09/06/2005 | US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders |
| 09/01/2005 | WO2005080368A2 Benzopyran compound useful for the treatment of arrhytmia |
| 09/01/2005 | WO2005080322A1 Fluorene derivative |
| 09/01/2005 | US20050192444 2,2-dimethyl 2H-1-benzopyran compound having a nitro group on the benzene ring thereof is reacted with hydrazine in the presence of a metal catalyst and the corresponding aminobenzopyran compound is produced; intermediates for synthesizing e.g., antifibrillatory agents |
| 09/01/2005 | US20050192316 Aryl aniline beta2 adrenergic receptor agonists |
| 09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/01/2005 | US20050191373 Agent for the prevention and/or treatment of septicemia |
| 09/01/2005 | DE102004004906A1 New oxygen-bridged angucyclinone derivatives, useful for treating bacterial infections and dementia, are modulators of intracellular calcium levels |
| 09/01/2005 | CA2537079A1 Fluorene derivative |
| 08/31/2005 | EP1568788A2 Aromatic sulfonic acids, their process of preparation, their aldehyde condensation products and their use in the field of leather, paper and textiles. |
| 08/31/2005 | EP1568774A2 Recombinant production of novel polyketides |
| 08/31/2005 | EP1567513A2 High enantiomeric purity dexanabinol for pharmaceutical copositions |
| 08/31/2005 | EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 08/31/2005 | EP1567498A2 Mandelic acid derivatives |
| 08/31/2005 | EP1326598B1 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 08/31/2005 | EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 08/31/2005 | CN1662508A Compounds, compositions and methods |
| 08/31/2005 | CN1660834A Compound containing o-naphthaquinone and application |
| 08/31/2005 | CN1660833A Compound containing structure of o-naphthaquinone and application |
| 08/31/2005 | CN1660832A Method for extracting and separating general flavone and saponin astragalus root from astragalus root |
| 08/31/2005 | CN1660796A Leather agent |
| 08/31/2005 | CN1660167A Effective part of astragalus, preparing method and application in pharmacy |
| 08/31/2005 | CN1216879C Process for producing alpha-tocopheryl acetate |
| 08/31/2005 | CN1216878C Process for poreparing genistein, medicinal composition and use thereof |
| 08/31/2005 | CN1216869C Polymorphic crystalline forms of celecoxib |
| 08/31/2005 | CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 08/30/2005 | US6936726 4-(2-Aminoethylthio)epicatechine derivatives as anticarcinogenic agents; cardiovascular diseases and aging resistance |
| 08/30/2005 | US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
| 08/30/2005 | US6936325 Optical recording medium |
| 08/25/2005 | WO2005077930A1 Phenolic compound purification |
| 08/25/2005 | WO2005077929A1 Phenolic compound purification |
| 08/25/2005 | WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |